Efficacy results of a 12-month, dose-level blinded study of CVT-301 (levodopa inhalation powder) in patients with Parkinson's diseaseEric S. Farbman,Mark Lew,Cheryl Hawthorne Waters,Robert A. Hauser,Michael Klingler,Charles OhMOVEMENT DISORDERS(2019)引用 1|浏览16暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要